Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
Taylor W. Schmitz, R. Nathan Spreng, Michael W. Weiner, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 284

Showing 1-25 of 284 citing articles:

The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Harald Hampel, M.‐Marsel Mesulam, A. Claudio Cuello, et al.
Brain (2018) Vol. 141, Iss. 7, pp. 1917-1933
Open Access | Times Cited: 1435
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
Dallas P. Veitch, Michael W. Weiner, Paul Aisen, et al.
Alzheimer s & Dementia (2018) Vol. 15, Iss. 1, pp. 106-152
Closed Access | Times Cited: 397
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
Li-Na Gao, Yun Zhang, Keenan Sterling, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 337
Amyloid precursor protein and endosomal‐lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease
Ralph A. Nixon
The FASEB Journal (2017) Vol. 31, Iss. 7, pp. 2729-2743
Open Access | Times Cited: 316
REVISITING THE CHOLINERGIC HYPOTHESIS IN ALZHEIMER’S DISEASE: EMERGING EVIDENCE FROM TRANSLATIONAL AND CLINICAL RESEARCH
Harald Hampel, M.‐Marsel Mesulam, A. Claudio Cuello, et al.
The Journal of Prevention of Alzheimer s Disease (2018), pp. 1-14
Closed Access | Times Cited: 271
Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits
Shreyasi Chatterjee, Amritpal Mudher
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 219
Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
Rashad Hussain, Hira Zubair, Sarah Pursell, et al.
Brain Sciences (2018) Vol. 8, Iss. 9, pp. 177-177
Open Access | Times Cited: 194
Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease
Jonathan Schulz, Gennaro Pagano, Juan Alberto Fernández Bonfante, et al.
Brain (2018) Vol. 141, Iss. 5, pp. 1501-1516
Open Access | Times Cited: 186
Quantification of brain cholinergic denervation in Alzheimer’s disease using PET imaging with [18F]-FEOBV
Meghmik Aghourian, Camille Legault-Denis, Soucy Jp, et al.
Molecular Psychiatry (2017) Vol. 22, Iss. 11, pp. 1531-1538
Closed Access | Times Cited: 184
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
George Crișan, Nastasia Sanda Moldovean-Cioroianu, Diana-Gabriela Timaru, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5023-5023
Open Access | Times Cited: 184
Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial
Gordon Wilcock, Serge Gauthier, Giovanni B. Frisoni, et al.
Journal of Alzheimer s Disease (2017) Vol. 61, Iss. 1, pp. 435-457
Open Access | Times Cited: 183
In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson’s disease
Nicola Ray, Steven Bradburn, Chris Murgatroyd, et al.
Brain (2017) Vol. 141, Iss. 1, pp. 165-176
Open Access | Times Cited: 182
Reimagining cholinergic therapy for Alzheimer’s disease
Ezio Giacobini, A. Claudio Cuello, Abraham Fisher
Brain (2022) Vol. 145, Iss. 7, pp. 2250-2275
Open Access | Times Cited: 122
Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images
Bingxin Zhao, Tengfei Li, Zirui Fan, et al.
Science (2023) Vol. 380, Iss. 6648
Closed Access | Times Cited: 121
The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease
Youjin Jung, Jessica S. Damoiseaux
Brain (2023) Vol. 147, Iss. 1, pp. 12-25
Open Access | Times Cited: 47
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial
Hayley R. C. Shanks, Kewei Chen, Eric M. Reiman, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1761-1770
Open Access | Times Cited: 17
Astrocyte-to-neuron H2O2 signalling supports long-term memory formation in Drosophila and is impaired in an Alzheimer’s disease model
Yasmine Rabah, Jean-Paul Berwick, Nisrine Sagar, et al.
Nature Metabolism (2025)
Open Access | Times Cited: 2
Exercise-induced brain-derived neurotrophic factor expression: Therapeutic implications for Alzheimer’s dementia
Rosy Wang, R. M. Damian Holsinger
Ageing Research Reviews (2018) Vol. 48, pp. 109-121
Closed Access | Times Cited: 157
Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF
Sumonto Mitra, Homira Behbahani, Maria Eriksdotter
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 140
Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology
Harald Hampel, Nicola Toschi, Claudio Babiloni, et al.
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. s1, pp. S47-S105
Open Access | Times Cited: 139
Normalization and the Cholinergic Microcircuit: A Unified Basis for Attention
Taylor W. Schmitz, John S. Duncan
Trends in Cognitive Sciences (2018) Vol. 22, Iss. 5, pp. 422-437
Closed Access | Times Cited: 124
Basal forebrain volume reliably predicts the cortical spread of Alzheimer’s degeneration
Sara Fernández‐Cabello, Martin Kronbichler, Koene R. A. Van Dijk, et al.
Brain (2020) Vol. 143, Iss. 3, pp. 993-1009
Open Access | Times Cited: 114
In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H positron emission tomography
Christine Bastin, Mohamed Ali Bahri, François Meyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2019) Vol. 47, Iss. 2, pp. 390-402
Open Access | Times Cited: 105
Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
Stuart P. McCluskey, Christophe Plisson, Eugenii A. Rabiner, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2019) Vol. 47, Iss. 2, pp. 451-489
Open Access | Times Cited: 105
ProNGF and Neurodegeneration in Alzheimer’s Disease
Margaret Fahnestock, Arman Shekari
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 104
Page 1 - Next Page

Scroll to top